Wed, Sep 17, 2014, 12:13 PM EDT - U.S. Markets close in 3 hrs 47 mins

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Nov 24, 2003 10:41 AM Flag

    IBD Monday 11/24 Insomnia Artical

    Page 9, Is The Drug Industry Asleep At The Wheel Regarding Insomnia? Indiplon will be the clear winner partly due to a better product marketing label and Pfizer as a power house marketing partner. Indiplon FY2007 sales projected @ $1.2 BILLION by some analyst and growing. That equates to Huge earnings for NBIX as its a 50/50 partnership in North America.
    SEPR Estorra Sales
    04, $50M
    05, $150M
    06, $300M
    07, $400m
    NBIX Indiplon
    05, $250M
    06, $647M
    07, $1.2Billion

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NBIX
16.04+0.44(+2.82%)12:10 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.